ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

FMS vs PGNY // DIVIDEND YIELD & FCF PAYOUT SAFETY

Fresenius Medical Care AG American (NYSE) VS. Progyny Inc. (NASDAQ) • 15-METRIC TALLY: FMS 4 — PGNY 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FMS VS. PGNY) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC FMS PGNY SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 23.60% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 9.90% 16.70% -6.80 PGNY /roic <GO>
EV/EBITDA & P/E Valuation 21.0x 20.5x +0.50 PGNY /valuation <GO>
Free Cash Flow Yield 2.21% 8.80% -6.59 PGNY /fcf-yield <GO>
Operating Margin 13.90% 6.60% +7.30 FMS /operating-margins <GO>
Net Profit Margin 10.90% 4.50% +6.40 FMS /net-margins <GO>
Revenue Growth (YoY) -3.30% 10.40% -13.70 PGNY /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.74 8.84 -5.10 PGNY /balance-sheet <GO>
Piotroski F-Score Quality 7/9 7/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 50.8 59.9 -9.10 PGNY /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.90 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 30.5x 34.6x -4.10 FMS /forward-pe <GO>
Enterprise Scale & Market Cap $12.55B $2.24B $10.31B FMS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR FMS REV PGNY REV FMS GROSS % PGNY GROSS % FMS FCF PGNY FCF
FY 2025 — $1.29B — 23.6% — $191.8M
FY 2024 — $1.17B — 21.7% — $173.7M
FY 2023 — $1.09B — — — $188.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FMS // BETA 0.90
PGNY // BETA —